10x Genomics Partners With Fred Hutchinson Cancer Center Over Use Of Single Cell, Spatial Technologies In Both Solid Tumor And Hematologic Malignancies

10x Genomics, Inc. (Nasdaq: TXG) has announced a multi-project research collaboration with the Fred Hutchinson Cancer Center to enhance the application of single cell and spatial technologies in the study of solid tumors and hematologic malignancies. This partnership aims to leverage advanced technologies to accelerate cancer research and improve human health.